Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

A prostate-specific antigen (PSA) test is a blood test that measures a protein released in the blood by prostate cells. Both normal and cancerous prostate cells release the protein. Most of the time, ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...

November means Movember. A global moment when men grow moustaches to create conversations around men’s health. At FirstMed, we use this month to emphasise crucial men’s health issues like prostate and ...

ABSTRACT: Introduction: Prostate surgery accounts for a significant proportion of urological surgical procedures. With the advent of endoscopy, conventional surgery has gradually given way to these ...

ABSTRACT: Introduction: Prostate surgery accounts for a significant proportion of urological surgical procedures. With the advent of endoscopy, conventional surgery has gradually given way to these ...

DEAR DR. ROACH: I am a 79-year-old female who is currently on biannual infusions for osteoporosis and high cholesterol. In 2018, I was diagnosed with Lynch syndrome with an MSH6 deviation. The genetic ...

Source: Getty Images Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection. Serum PSA testing is not specific to prostate cancer, and ...

The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...

People with diabetes may experience changes in their urinary and digestive health, and research shows there may be different effects on the body impacting the development of prostate cancer. Diabetes ...

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

Those with prostate cancer that returns after surgery or radiation—and typically face a high risk of the disease spreading and death—could benefit from a new drug combination. A Cedars-Sinai Medical ...